Haemonetics Corporation
HAE
$56.66
-$1.80-3.08%
NYSE
| 12/27/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/28/2024 | |
|---|---|---|---|---|---|
| Net Income | 19.33% | 14.34% | -11.32% | 184.68% | 20.02% |
| Total Depreciation and Amortization | -5.65% | -3.29% | -1.30% | 12.97% | 23.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -22.09% | -- |
| Total Other Non-Cash Items | -23.38% | 39.22% | 163.24% | -405.23% | 6.96% |
| Change in Net Operating Assets | 133.43% | 195.34% | 29.75% | 225.50% | 47.33% |
| Cash from Operations | 113.78% | 128.01% | 163.44% | 81.89% | 8,204.81% |
| Capital Expenditure | 25.71% | 46.82% | 33.63% | -134.00% | 41.65% |
| Sale of Property, Plant, and Equipment | 72.11% | -36.51% | -98.54% | 344.83% | -25.74% |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | 2,786.07% | -- |
| Other Investing Activities | -159.46% | -106.76% | -521.70% | -43.18% | 15.78% |
| Cash from Investing | -69.63% | -30.39% | 76.29% | 238.17% | 93.54% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -0.06% | -- | 99.69% | 97.54% | 55.37% |
| Issuance of Common Stock | 6.50% | -74.90% | -10.54% | 32.08% | 21.32% |
| Repurchase of Common Stock | 64.37% | 0.04% | 50.96% | -- | -944.19% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 90.60% | -254.55% | 99.97% | 75.00% | -375.93% |
| Cash from Financing | 47.32% | -2.34% | -100.73% | -138.50% | -98.74% |
| Foreign Exchange rate Adjustments | 113.04% | -118.40% | 389.41% | 202.55% | -305.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 210.44% | 107.81% | -108.37% | 7.21% | 113.73% |